SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-19-009010
Filing Date
2019-05-16
Accepted
2019-05-16 16:18:21
Documents
1
Group Members
ENRICOCAVAZZAFRANCESCACAVAZZAMARTINACAVAZZA PRETAPAOLOCAVAZZASILVIACAVAZZA

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 23 TO SCHEDULE 13D sc13d0519a23essetifin_regene.htm SC 13D/A 160352
  Complete submission text file 0001213900-19-009010.txt   162090
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 19832473
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 ROME L6 00144
Business Address
Essetifin SPA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: SC 13D/A